Johnson & Johnson's ($JNJ) stellar year for drug approvals continues. U. S. regulators have given a market nod to J&J unit Janssen's extended-release version of pain pill Nucynta.
强生公司的止痛药现已再次获得FDA批准上市，美国官方已经允许强生将该药Nucynta投放市场中。
Johnson & Johnson's ($JNJ) stellar year for drug approvals continues. U. S. regulators have given a market nod to J&J unit Janssen's extended-release version of pain pill Nucynta.
强生公司的止痛药现已再次获得FDA批准上市，美国官方已经允许强生将该药Nucynta投放市场中。
应用推荐